Dual inhibition of MAT2A and PRMT5 delivers synergistic anti-tumor responses in preclinical models of MTAP-deleted cancer

被引：3
|
作者：
Fischer, Marcus M.
Gerrick, Kimberline
Belmontes, Brian
Slemmons, Katherine
Freyman, Yevgeniy
Jain, Jay
Federowicz, Steve
Bishof, Isaac
Rao, Arjun A.
Fleury, Melissa
Mounir, Zineb
Lackner, Mark R.
Hughes, Paul E.
White, Mike
Neilan, Claire L.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1644
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1644
引用
收藏
页数：2
相关论文
共 18 条
  • [1] The mechanistic basis of both deep and durable antitumor activity by combinatorial inhibition of MAT2A and PRMT5 in MTAP-deleted tumors
    Garbett, D.
    Rao, A. A.
    Fischer, M. M.
    Belmontes, B.
    Slemmons, K.
    Appel, M. J.
    Fang, Z.
    Choy, R.
    Tyler, S. R.
    Vivian, J.
    Freyman, Y.
    Magallanes, K.
    Lanham, P.
    Rathore, A.
    Li, A.
    Aubi, O.
    Hughes, P. E.
    Teriete, P.
    White, M. A.
    Neilan, C. L.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S84 - S84
  • [2] Cancer Dependencies: PRMT5 and MAT2A in MTAP/p16-Deleted Cancers
    Marjon, Katya
    Kalev, Peter
    Marks, Kevin
    ANNUAL REVIEW OF CANCER BIOLOGY, VOL 5, 2021, 2021, 5 : 371 - 390
  • [3] Combined inhibition of MTAP and MAT2a mimics synthetic lethality in tumor models via PRMT5 inhibition
    Bedard, Gabriel T.
    Gilaj, Nord
    Peregrina, Karina
    Brew, Isabella
    Tosti, Elena
    Shaffer, Karl
    Tyler, Peter C.
    Edelmann, Winfried
    Augenlicht, Leonard H.
    Schramm, Vern L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (01)
  • [4] AZ-PRMT5i-1: A potent MTAP-selective PRMT5 inhibitor with pharmacodynamic and monotherapy anti-tumor activity in MTAP-deleted tumours
    Lynch, James T.
    Moore, Shaun
    Barrantes, Ivan Del Barco
    Bradshaw, Lauren
    Chambers, Chris
    Hong, Ted
    Cooke, Sophie
    Urosevic, Jelena
    Vazquez-Chantada, Mercedes
    Smith, James M.
    Cronin, Anna
    Recolin, Benedicte
    Gill, Sonja
    Critchlow, Susan
    Chan, Ho Man
    Dean, Emma
    CANCER RESEARCH, 2023, 83 (07)
  • [5] MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage
    Kalev, Peter
    Hyer, Marc L.
    Gross, Stefan
    Konteatis, Zenon
    Chen, Chi-Chao
    Fletcher, Mark
    Lein, Max
    Aguado-Fraile, Elia
    Frank, Victoria
    Barnett, Amelia
    Mandley, Everton
    Goldford, Joshua
    Chen, Yue
    Sellers, Katie
    Hayes, Sebastian
    Lizotte, Kate
    Quang, Phong
    Tuncay, Yesim
    Clasquin, Michelle
    Peters, Rachel
    Weier, Jaclyn
    Simone, Eric
    Murtie, Joshua
    Liu, Wei
    Nagaraja, Raj
    Dang, Lenny
    Sui, Zhihua
    Biller, Scott A.
    Travins, Jeremy
    Marks, Kevin M.
    Marjon, Katya
    CANCER CELL, 2021, 39 (02) : 209 - +
  • [6] PRMT5 inhibition synergizes with a natural small molecule compound to kill MTAP-deleted cells and suppress tumor growth
    Barekatain, Yasaman
    LaBella, Kyle
    Sugimoto, Hikaru
    Harris, Kristen
    Khadka, Sunada
    Muller, Florian
    Kalluri, Raghu
    CANCER RESEARCH, 2023, 83 (07)
  • [7] MTAP deletions in cancer create vulnerability to a MAT2A/PRMT5/RIOK1 axis
    Marks, Kevin
    CANCER RESEARCH, 2016, 76
  • [8] MTA-COOPERATIVE PRMT5 INHIBITORS ARE EFFICACIOUS IN MTAP-DELETED MALIGNANT PERIPHERAL NERVE SHEATH TUMOR MODELS
    Borcherding, Dana
    Zhang, Xiaochun
    Zhang, Minjie
    Bhatia, Himanshi
    Lyu, Yang
    He, Kevin
    Yang, Liuzhan
    Yang, Kuangying
    DiBenedetto, Heather
    Tsai, Alice
    Huang, Alan
    Maxwell, John
    Cottrell, Kevin
    Briggs, Kimberly
    Hirbe, Angela
    NEURO-ONCOLOGY, 2023, 25
  • [9] MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis
    Marjon, Katya
    Cameron, Michael J.
    Quang, Phong
    Clasquin, Michelle F.
    Mandley, Everton
    Kunii, Kaiko
    Mcvay, Michael
    Choe, Sung
    Kernytsky, Andrew
    Gross, Stefan
    Konteatis, Zenon
    Murtie, Joshua
    Blake, Michelle L.
    Travins, Jeremy
    Dorsch, Marion
    Biller, Scott A.
    Marks, Kevin M.
    CELL REPORTS, 2016, 15 (03): : 574 - 587
  • [10] Targeting MTAP-deleted tumor via synthetic lethality with a combination of a PRMT5i and an MAT2Ai
    Zhang, Guiping
    Li, Jiapeng
    Li, Jie Jack
    CANCER RESEARCH, 2024, 84 (06)
12